Posterior Basolateral Amygdala is a Critical Amygdaloid Area for Temporal Lobe Epilepsy

Area of Science:

• Neuroscience
• Epileptology
• Molecular Biology

Background:

• The amygdaloid complex is implicated in temporal lobe epilepsy (TLE), but specific nuclei and circuits remain unclear.
• Understanding the neural basis of TLE is crucial for developing effective treatments.

Purpose of the Study:

• To identify the specific nucleus within the amygdaloid complex that controls seizures in TLE.
• To elucidate the neural circuitry underlying seizure generation and regulation originating from the amygdala.

Main Methods:

• Utilized optogenetic stimulation and chemogenetic manipulation of specific neuronal populations in rodent models.
• Investigated neuronal projections and functional connections between the posterior basolateral amygdala (pBLA) and other brain regions like the insular cortex (IC), bed nucleus of the stria terminalis (BNST), and central amygdala (CeA).
• Examined the role of glutamatergic and GABAergic neurons in seizure dynamics and employed ablation techniques in a TLE mouse model.

Main Results:

• Activation of glutamatergic neurons in the posterior basolateral amygdala (pBLA) robustly induced severe seizures and mortality.
• pBLA glutamatergic neurons project to the IC, BNST, and CeA; stimulating pBLA-targeted IC neurons triggered seizures, while IC neuron ablation suppressed pBLA-induced seizures.
• GABAergic neurons in the BNST and CeA provide feedback inhibition to pBLA neurons, and their deletion caused sporadic seizures.
• Ventral hippocampal CA1 (vCA1) glutamatergic inputs to pBLA were identified.
• Ablation of pBLA glutamatergic neurons significantly reduced seizures in a TLE mouse model.

Conclusions:

• The posterior basolateral amygdala (pBLA) is a critical nucleus in the amygdaloid complex for regulating epileptic seizures in TLE.
• The pBLA-IC pathway is pro-convulsant, while BNST and CeA GABAergic feedback provides seizure control.
• Targeting pBLA glutamatergic neurons represents a promising therapeutic avenue for TLE.